Health Care [ 4/12 ] | Pharmaceuticals [ 25/74 ]
NASDAQ | Common Stock
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products.
It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.
It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians.
ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Feb 26, 25 | -0.55 Decreased by -155.00% | 0.29 Decreased by -287.52% |
| Nov 8, 24 | 1.34 Increased by +5.51% | 1.09 Increased by +22.94% |
| Aug 6, 24 | 1.02 Decreased by -20.31% | 0.95 Increased by +7.37% |
| May 10, 24 | 1.21 Increased by +3.42% | 1.00 Increased by +21.00% |
| Feb 29, 24 | 1.00 Increased by +31.58% | 0.86 Increased by +16.28% |
| Nov 8, 23 | 1.27 Increased by +98.44% | 0.84 Increased by +51.19% |
| Aug 9, 23 | 1.28 Increased by +884.62% | 0.68 Increased by +88.24% |
| May 8, 23 | 1.17 Increased by +1.07 K% | 0.35 Increased by +234.29% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 24 | 190.57 M Increased by +44.75% | -10.28 M Decreased by -989.70% | Decreased by -5.39% Decreased by -714.63% |
| Sep 30, 24 | 148.33 M Increased by +12.52% | -24.17 M Decreased by -343.12% | Decreased by -16.29% Decreased by -316.07% |
| Jun 30, 24 | 138.04 M Increased by +18.44% | -2.29 M Decreased by -136.62% | Decreased by -1.66% Decreased by -130.92% |
| Mar 31, 24 | 137.43 M Increased by +28.70% | 18.21 M Increased by +1.17 K% | Increased by +13.25% Increased by +883.13% |
| Dec 31, 23 | 131.65 M Increased by +39.71% | 1.16 M Increased by +127.22% | Increased by +0.88% Increased by +119.48% |
| Sep 30, 23 | 131.83 M Increased by +57.27% | 9.94 M Increased by +215.58% | Increased by +7.54% Increased by +173.49% |
| Jun 30, 23 | 116.55 M Increased by +57.81% | 6.25 M Increased by +141.85% | Increased by +5.36% Increased by +126.52% |
| Mar 31, 23 | 106.79 M Increased by +65.62% | 1.44 M Increased by +107.15% | Increased by +1.35% Increased by +104.32% |